Is Intrinsic Cardioprotection a Laboratory Phenomenon or a Clinically Relevant Tool to Salvage the Failing Heart?
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242216497 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Tanya Ravingerova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Heart Research, Centre of Experimental Medicine, Slovak Academy of Sciences, 9 Dubravska cesta, 841 04 Bratislava, Slovakia. Hauptthemen laut MEDLINE: Ischemic Preconditioning, Myocardial, Myocardial Ischemia, Myocardial Infarction, Heart Failure. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Slovak Research and Development Agency, Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic, EU Structural funds.
Abstract (Originalsprache)
Cardiovascular diseases, especially ischemic heart disease, as a leading cause of heart failure (HF) and mortality, will not reduce over the coming decades despite the progress in pharmacotherapy, interventional cardiology, and surgery. Although patients surviving acute myocardial infarction live longer, alteration of heart function will later lead to HF. Its rising incidence represents a danger, especially among the elderly, with data showing more unfavorable results among females than among males. Experiments revealed an infarct-sparing effect of ischemic “preconditioning” (IPC) as the most robust form of innate cardioprotection based on the heart’s adaptation to moderate stress, increasing its resistance to severe insults. However, translation to clinical practice is limited by technical requirements and limited time. Novel forms of adaptive interventions, such as “remote” IPC, have already been applied in patients, albeit with different effectiveness. Cardiac ischemic tolerance can also be increased by other noninvasive approaches, such as adaptation to hypoxia- or exercise-induced preconditioning. Although their molecular mechanisms are not yet fully understood, some noninvasive modalities appear to be promising novel strategies for fighting HF through targeting its numerous mechanisms. In this review, we will discuss the molecular mechanisms of heart injury and repair, as well as interventions that have potential to be used in the treatment of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Heart Research, Centre of Experimental Medicine, Slovak Academy of Sciences, 9 Dubravska cesta, 841 04 Bratislava, Slovakia.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, 10 Odbojárov St., 832 32 Bratislava, Slovakia.
- School of Biology, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
- Department of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus.
- Department of Anatomy, Faculty of Medicine, Comenius University in Bratislava, 24 Špitalska, 813 72 Bratislava, Slovakia.
- Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, 19 Innovation Walk, Clayton, VIC 3800, Australia.
ORCID-Profile: Tanya Ravingerova, Miroslav Ferko, Branislav Kura, Jan Slezak, Eleftheria Galatou, Antigone Lazou
Förderung
- The Slovak Research and Development Agency
- Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic
- EU Structural funds
- Ministry of Health of The Slovak Republic
Zitieren
APA
Ravingerova, T., Adameova, A., Lonek, L., Farkasova, V., Ferko, M., Andelova, N., Kura, B., Slezak, J., Galatou, E., Lazou, A., Zohdi, V., & Dhalla, N. S. (2023). Is Intrinsic Cardioprotection a Laboratory Phenomenon or a Clinically Relevant Tool to Salvage the Failing Heart?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216497
Vancouver
Ravingerova T, Adameova A, Lonek L, Farkasova V, Ferko M, Andelova N, et al. Is Intrinsic Cardioprotection a Laboratory Phenomenon or a Clinically Relevant Tool to Salvage the Failing Heart?. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216497
BibTeX
@article{Ravingerova2023,
author = {Ravingerova, Tanya and Adameova, Adriana and Lonek, Lubomir and Farkasova, Veronika and Ferko, Miroslav and Andelova, Natalia and Kura, Branislav and Slezak, Jan and Galatou, Eleftheria and Lazou, Antigone and Zohdi, Vladislava and Dhalla, Naranjan S},
title = {Is Intrinsic Cardioprotection a Laboratory Phenomenon or a Clinically Relevant Tool to Salvage the Failing Heart?},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242216497}
}
EUVIMED